Evidence map›Paper›PMID 37185882›Full record

ArticleTobacco control2024

Tobacco industry interference to undermine the development and implementation of graphic health warnings in Bangladesh.

Md Hasan Shahriar, Md Mehedi Hasan, Md Shahedul Alam, Britta K Matthes, Anna B Gilmore, A B M Zubair

Abstract read
In one paragraph

Article in Tobacco control, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Md Hasan ShahriarPROGGA: Knowledge for Progress, Dhaka, Bangladesh.
Md Mehedi HasanPROGGA: Knowledge for Progress, Dhaka, Bangladesh.
Md Shahedul AlamPROGGA: Knowledge for Progress, Dhaka, Bangladesh.
Britta K MatthesDepartment for Health, University of Bath, Bath, UK.ORCID 0000-0003-2346-066X
Anna B GilmoreDepartment for Health, University of Bath, Bath, UK.ORCID 0000-0003-0281-1248
A B M ZubairPROGGA: Knowledge for Progress, Dhaka, Bangladesh progga.bd@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Bangladesh, the 2013 Amendment of the Tobacco Control Act made graphic health warnings (GHWs) on the

methodsAnalysis of print and electronic media articles and documents.

resultsCigarette companies actively opposed GHWs, while bidi companies did not. The primary strategy used to influence the formulation and delay the implementation of GHWs was direct lobbying by the Bangladesh Cigarette Manufacturers' Association and British American Tobacco Bangladesh. Their arguments stressed the economic benefits of tobacco to Bangladesh and sought to create confusion about the impact of GHWs, for example, claiming that GHWs would obscure tax banderols, thus threatening revenue collection. They also claimed technical barriers to implementation-that new machinery would be needed-leading to delays. Tensions between government bodies were identified, one of which (National Board of Revenue)-seemingly close to cigarette companies and representing their arguments-sought to influence others to adopt industry-preferred positions. Finally, although tobacco control advocates were partially successful in counteracting TII, one self-proclaimed tobacco control group, whose nature remains unclear, threatened the otherwise united approach.

conclusionsThe strategies cigarette companies used closely resemble key techniques from the well-evidenced tobacco industry playbook. The study underlines the importance of continuing monitoring and investigations into industry conduct and suspicious actors. Prioritising the implementation of WHO Framework Convention on Tobacco Control Article 5.3 is crucial for advancing tobacco control, particularly in places like Bangladesh, where close government-industry links exist.

Indexed as

Product LabelingTobacco IndustryTobacco ProductsBangladeshHumansLobbyingSmoking PreventionAdvocacyLow/Middle income countryPackaging and LabellingPublic policyTobacco industry

Identifiers

PMID37185882
PMCPMC11503176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.